SPOTLIGHT -
Atlanta-CIBA Vision's Focus Night & Day 30-day contact lenses will be marketed throughout Europe after receiving the CE Mark for therapeutic use.
WVU Medicine to expand, relocate WVU Eye Institute
(EyePod) From idea to impact: Navigating ophthalmic innovation
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410
EyePod: Modifier Gene Therapy: What is it?
Intracortical Visual Prosthesis achieves 2 years of successful testing
SalioGen Therapeutics taps development candidate for ABCA4-mediated Stargardt disease